Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Name: Tislelizumab and Radiotherapy for Recurrent Cervical Cancer
License: Public Domain

Lei Li

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti immunotherapy radiotherapy

recurrent cervical carcinoma, metastatic cervical carcinoma, persistent cervical carcinoma, radiotherapy, immunotherapy, anti-programmed cell death receptor 1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287534
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.